UW Department of Global Health researchers presented new HIV prevention findings at the HIV Research for Prevention (HIVR4P 2018) conference in Madrid. HIVR4P is the only global scientific conference focused exclusively on the challenging and fast-growing field of biomedical HIV prevention research. The conference supports global cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches.
Midway into a study in which all participants are offered use of a monthly vaginal ring containing an antiretroviral (ARV) drug called dapivirine, researchers have seen women's risk of acquiring HIV reduced by more than half.
By Matthew Sedacca
In recent years scientists studying genital microbiomes have focused on the possible connection between HIV incidence in men and the penile microbiome, the community of microorganisms living on the penis.
By Tony Kirby
"The last person that I train, I want that training to be in something other than HIV", says Jared Baeten. Speaking to The Lancet Infectious Diseases from the HIV Research for Prevention Conference (HIVR4P) in Chicago, IL, where he brought a 12-strong team of his researchers, Baeten explains: “When that time comes, I want HIV to have been eliminated as public health threat, so we can focus on other diseases”.
Jared Baeten, MD, PhD, current Vice Chair of the Department of Global Health, has accepted the position of Director of the University of Washington/Fred Hutch Center for AIDS Research (CFAR) starting January 1, 2017. After 30 years as CFAR Director, King Holmes will transition to a Co-Director role and will remain an active member of the CFAR Leadership Team.
Researchers saw 95% fewer cases than expected; model offered antiretroviral meds to HIV-infected members and preventive therapy for uninfected partners
Providing HIV medication to both members of a HIV-serodiscordant couple substantially reduced the risk of transmission within that couple, according to a study published Aug. 23 in PLOS Medicine.
The University of Washington is one of 56 DREAMS Innovation Challenge winners* announced on Monday by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare.
New data analyses finds that a monthly vaginal ring containing an antiretroviral drug called dapivirine can cut women’s HIV risk by more than half and, in some, by 75 percent or more.
One of the researchers, Jared Baeten, a University of Washington professor of epidemiology, medicine and global health, presented the results Tuesday at the AIDS 2016 conference in Durban, South Africa.
By Lucy Tiven
On Tuesday, the Journal of the American Medical Association published a study on antiretroviral therapy (ART) and HIV transmission in mixed status couples — couples where one partner is HIV positive.
By Randy Dotinga
TUESDAY, July 12, 2016 (HealthDay News) -- HIV transmission is highly unlikely among straight couples who have sex without condoms when one partner carries the virus but takes medication, new research suggests.
For gay couples in the same scenario, the risk seems to be only slightly higher.